Expansion of human megakaryocyte-biased hematopoietic stem cells by biomimetic Microniche
-
Published:2023-04-18
Issue:1
Volume:14
Page:
-
ISSN:2041-1723
-
Container-title:Nature Communications
-
language:en
-
Short-container-title:Nat Commun
Author:
Li YinghuiORCID, He MeiORCID, Zhang Wenshan, Liu Wei, Xu Hui, Yang Ming, Zhang Hexiao, Liang Haiwei, Li Wenjing, Wu Zhaozhao, Fu Weichao, Xu Shiqi, Liu Xiaolei, Fan Sibin, Zhou Liwei, Wang Chaoqun, Zhang Lele, Li Yafang, Gu Jiali, Yin Jingjing, Zhang Yiran, Xia Yonghui, Mao Xuemei, Cheng TaoORCID, Shi Jun, Du YananORCID, Gao YingdaiORCID
Abstract
AbstractLimited numbers of available hematopoietic stem cells (HSCs) limit the widespread use of HSC-based therapies. Expansion systems for functional heterogenous HSCs remain to be optimized. Here, we present a convenient strategy for human HSC expansion based on a biomimetic Microniche. After demonstrating the expansion of HSC from different sources, we find that our Microniche-based system expands the therapeutically attractive megakaryocyte-biased HSC. We demonstrate scalable HSC expansion by applying this strategy in a stirred bioreactor. Moreover, we identify that the functional human megakaryocyte-biased HSCs are enriched in the CD34+CD38-CD45RA-CD90+CD49f lowCD62L-CD133+ subpopulation. Specifically, the expansion of megakaryocyte-biased HSCs is supported by a biomimetic niche-like microenvironment, which generates a suitable cytokine milieu and supplies the appropriate physical scaffolding. Thus, beyond clarifying the existence and immuno-phenotype of human megakaryocyte-biased HSC, our study demonstrates a flexible human HSC expansion strategy that could help realize the strong clinical promise of HSC-based therapies.
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary
Reference57 articles.
1. Doulatov, S., Notta, F., Laurenti, E. & Dick, J. E. Hematopoiesis: a human perspective. Cell Stem Cell 10, 120–136 (2012). 2. Derderian, S. C., Jeanty, C., Walters, M. C., Vichinsky, E. & MacKenzie, T. C. In utero hematopoietic cell transplantation for hemoglobinopathies. Front. Pharmacol. 5, 278 (2014). 3. Spivak, J. L. Myeloproliferative neoplasms. N. Engl. J. Med. 376, 2168–2181 (2017). 4. Huang, X., Guo, B., Capitano, M. & Broxmeyer, H. E. Past, present, and future efforts to enhance the efficacy of cord blood hematopoietic cell transplantation. F1000Res 8 https://doi.org/10.12688/f1000research.20002.1 (2019). 5. Sugimura, R. et al. Haematopoietic stem and progenitor cells from human pluripotent stem cells. Nature 545, 432–438 (2017).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|